Release Date: 29/07/09 14:45 Summary: Quarterly Activities and Cashflow Reports Price Sensitive: Yes Download Document 1.23MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%